PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
Prognostic markers for CLL - how do they help determine who gets which treatment?
CLL update from ICML17: Current treatment and future directions for patients
Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL
Why is personalized medicine important for CLL?